STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ZBH ZIMMER BIOMET HOLDINGS INCORPORATED StockScouter® Report
4
StockScouter® Score
ZIMMER BIOMET HOLDINGS INCORPORATED, a large cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
- The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but is not suggestive of future returns. Neutral
Concerns
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for ZBH. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
D
D
D